Molecular Neurobiology

, Volume 53, Issue 7, pp 4931–4938 | Cite as

Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson’s Disease Susceptibility

  • Guiyou Liu
  • Yongquan Liu
  • Qinghua Jiang
  • Yongshuai Jiang
  • Rennan Feng
  • Liangcai Zhang
  • Zugen Chen
  • Keshen LiEmail author
  • Jiafeng LiuEmail author


A rare TREM2 missense mutation (rs75932628-T) was reported to confer a significant Alzheimer’s disease (AD) risk. A recent study indicated no evidence of the involvement of this variant in Parkinson’s disease (PD). Here, we used the genetic and expression data to reinvestigate the potential association between TREM2 and PD susceptibility. In stage 1, using 10 independent studies (N = 89,157; 8787 cases and 80,370 controls), we conducted a subgroup meta-analysis. We identified a significant association between rs75932628 and PD (P = 3.10E-03, odds ratio (OR) = 3.88, 95 % confidence interval (CI) 1.58–9.54) in No-Northern Europe subgroup, and significantly increased PD risks (P = 0.01 for Mann–Whitney test) in No-Northern Europe subgroup than in Northern Europe subgroup. In stage 2, we used the summary results from a large-scale PD genome-wide association study (GWAS; N = 108,990; 13,708 cases and 95,282 controls) to search for other TREM2 variants contributing to PD susceptibility. We identified 14 single-nucleotide polymorphisms (SNPs) associated with PD within 50-kb upstream and downstream range of TREM2. In stage 3, using two brain expression GWAS datasets (N = 773), we identified 6 of the 14 SNPs regulating increased expression of TREM2. In stage 4, using the whole human genome microarray data (N = 50), we further identified significantly increased expression of TREM2 in PD cases compared with controls in human prefrontal cortex. In summary, convergent genetic and expression datasets demonstrate that TREM2 is a potent risk factor for PD and may be a therapeutic target in PD and other neurodegenerative diseases.


TREM2 rs75932628 Parkinson’s disease Alzheimer’s disease Genome-wide association study 



This work was supported by funding from the National Nature Science Foundation of China (Grant No. 81300945 and 81471294).

Conflict of interest

The authors reported no potential conflicts of interest.


  1. 1.
    Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J et al (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368:107–116CrossRefPubMedGoogle Scholar
  2. 2.
    Lill CM, Rengmark A, Pihlstrom L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T et al (2015) The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Alzheimers DementGoogle Scholar
  3. 3.
    Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C et al (2013) TREM2 in neurodegeneration: evidence for association of the p.R47h variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener 8:19CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Benitez BA, Cruchaga C (2013) TREM2 and neurodegenerative disease. N Engl J Med 369:1567–1568PubMedPubMedCentralGoogle Scholar
  5. 5.
    Jonsson T, Stefansson K (2013) TREM2 and neurodegenerative disease. N Engl J Med 369:1568–1569PubMedGoogle Scholar
  6. 6.
    Rothwell PM (2005) Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365:176–186CrossRefPubMedGoogle Scholar
  7. 7.
    Liu G, Li F, Zhang S, Jiang Y, Ma G, Shang H, Liu J, Feng R et al. Analyzing large-scale samples confirms the association between the abca7 rs3764650 polymorphism and alzheimer's disease susceptibility. Mol Neurobiol 2014Google Scholar
  8. 8.
    Chen H, Wu G, Jiang Y, Feng R, Liao M, Zhang L, Ma G, Chen Z et al (2014) Analyzing 54,936 samples supports the association between cd2ap rs9349407 polymorphism and Alzheimer's disease susceptibility. Mol NeurobiolGoogle Scholar
  9. 9.
    Liu G, Zhang S, Cai Z, Ma G, Zhang L, Jiang Y, Feng R, Liao M et al (2013) PICALM gene rs3851179 polymorphism contributes to Alzheimer's disease in an Asian population. Neuromolecular Med 15:384–388CrossRefPubMedGoogle Scholar
  10. 10.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046–1055CrossRefPubMedGoogle Scholar
  13. 13.
    Song F, Khan KS, Dinnes J, Sutton AJ (2002) Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31:88–95CrossRefPubMedGoogle Scholar
  14. 14.
    Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46:989–993CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E et al (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 8:e1002548CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN et al (2012) Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 8:e1002707CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Dumitriu A, Latourelle JC, Hadzi TC, Pankratz N, Garza D, Miller JP, Vance JM, Foroud T et al (2012) Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet 8:e1002794CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC et al (2014) Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol Aging 35:1510 e1519–1526CrossRefGoogle Scholar
  19. 19.
    Replogle JM, Chan G, White CC, Raj T, Winn PA, Evans DA, Sperling RA, Chibnik LB et al (2015) A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol 77:469–477CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45:1452–1458CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V (2014) The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia. Alzheimers DementGoogle Scholar
  22. 22.
    Lue LF, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG (2014) Trem2 protein expression changes correlate with Alzheimer's disease neurodegenerative pathologies in post-mortem temporal cortices. Brain PatholGoogle Scholar
  23. 23.
    Hu N, Tan MS, Yu JT, Sun L, Tan L, Wang YL, Jiang T (2014) Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. J Alzheimers Dis 38:497–501PubMedGoogle Scholar
  24. 24.
    Strobel S, Grunblatt E, Riederer P, Heinsen H, Arzberger T, Al-Sarraj S, Troakes C, Ferrer I et al (2015) Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARgamma. J Neural TransmGoogle Scholar
  25. 25.
    Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J et al (2014) TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71:449–453CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Feng SJ, Nie K, Gan R, Huang J, Zhang YW, Wang LM, Zhao JH, Tang HM et al (1780) Triggering receptor expressed on myeloid cells 2 variants are rare in Parkinson's disease in a Han Chinese cohort. Neurobiol Aging 2014(35):e1711–1782Google Scholar
  27. 27.
    Chen Y, Chen X, Guo X, Song W, Cao B, Wei Q, Ou R, Zhao B et al (2015) Assessment of TREM2 rs75932628 association with Parkinson's disease and multiple system atrophy in a Chinese population. Neurol SciGoogle Scholar
  28. 28.
    Lin WY, Lou XY, Gao G, Liu N (2014) Rare variant association testing by adaptive combination of p-values. PLoS One 9:e85728CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Clarke GM, Rivas MA, Morris AP (2013) A flexible approach for the analysis of rare variants allowing for a mixture of effects on binary or quantitative traits. PLoS Genet 9:e1003694CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X (2011) Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89:82–93CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Yang J, Lee SH, Goddard ME, Visscher PM (2011) GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88:76–82CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Guiyou Liu
    • 1
  • Yongquan Liu
    • 2
  • Qinghua Jiang
    • 3
  • Yongshuai Jiang
    • 4
  • Rennan Feng
    • 5
  • Liangcai Zhang
    • 6
  • Zugen Chen
    • 7
  • Keshen Li
    • 8
    • 9
    Email author
  • Jiafeng Liu
    • 2
    Email author
  1. 1.Genome Analysis Laboratory, Tianjin Institute of Industrial BiotechnologyChinese Academy of SciencesTianjinChina
  2. 2.Department of NeurologyThe First Hospital of HarbinHarbinChina
  3. 3.School of Life Science and TechnologyHarbin Institute of TechnologyHarbinChina
  4. 4.College of Bioinformatics Science and TechnologyHarbin Medical UniversityHarbinChina
  5. 5.Department of Nutrition and Food Hygiene, School of Public Health,Harbin Medical UniversityHarbinChina
  6. 6.Department of StatisticsRice UniversityHoustonUSA
  7. 7.Department of Human GeneticsUniversity of California at Los AngelesLos AngelesUSA
  8. 8.Institute of NeurologyAffiliated Hospital of Guangdong Medical CollegeZhanjiangChina
  9. 9.Stroke Center, Neurology & Neurosurgery Division, The Clinical Medicine Research Institute & The First Affiliated HospitalJinan University GuangzhouGuangzhouChina

Personalised recommendations